Travere Therapeutics Inc (TVTX)
R&D Expense Growth
5.59%
Quarterly · Period ending:
TVTX R&D Expense Growth
Latest reported5.59%period ending
Latest reported5.59%period ending
TVTX Quarterly R&D Growth (QoQ) (0.00% → 5.59%)
Latest values, visible window
High-resolution chart · PNG
TVTX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 5.5855% | |
| -1.3409% | |
| 11.5244% | |
| 5.1213% | |
| 5.2742% | |
| -24.4542% | |
| 20.101% | |
| -4.8794% | |
| -52.602% | |
| 95.1097% | |
| -3.0385% | |
| -8.8763% | |
| 10.9809% | |
| -0.5296% | |
| 5.402% | |
| -4.2493% | |
| 5.423% | |
| -8.9387% | |
| 28.4277% | |
| -6.5628% | |
| 8.0528% | |
| 24.9049% | |
| 18.6621% | |
| 5.0633% | |
| 1.7885% | |
| -16.1474% | |
| 8.5912% | |
| -12.4268% | |
| 13.4288% | |
| 4.5257% | |
| -1.3961% | |
| -5.8387% | |
| 39.8766% | |
| 25.848% | |
| -0.1734% | |
| 0.657% | |
| -6.6059% | |
| 3.8948% | |
| 8.9538% | |
| 4.2603% | |
| 20.4676% | |
| -5.0479% | |
| 9.8692% | |
| 33.144% | |
| 2.0929% | |
| -27.0954% | |
| 9.0105% | |
| -4.9588% | |
| 98.9043% | |
| 38.5605% | |
| 255.0457% | |
| 131.3067% | |
| 281.3744% | |
| -57.7517% | |
| 239.4421% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |